💰 TREATING MENOPAUSE COULD BE CHEAPER THAN NOT TREATING IT — A cost-effectiveness model found that putting 10,000 fifty-year-old women with hot flashes on five years of transdermal estrogen could save roughly $135 million and prevent 647 deaths, largely from cardiovascular disease. The model projected 87 additional breast cancer cases — but also 259 fewer cases of heart disease and 181 fewer hip fractures.
💊 FDA WANTS OPINIONS ON TESTOSTERONE FOR WOMEN — Off-label use of testosterone for menopausal women has climbed for a decade, so the FDA’s Office of Women’s Health is convening a public workshop on the topic with comments open through October 19. Beyond 24 months of use, the agency says safety data is limited — “particularly regarding cardiovascular and breast cancer risks.”
👶🏽 DOULAS WORK, REVIEW FINDS — A review of 30 studies found doula support was associated with lower rates of preterm birth and C-sections, better birth experiences, and higher attendance at the 6-week postpartum check-up. The benefits held — and sometimes were strongest — among people facing racial, income, insurance, or incarceration-related disparities.
TOP CLICKED THIS WEEK
The Anti-Abortion Movement’s Next Target: Surrogacy // Texas Tribune
Testosterone for Women Workshopping // Federal Register
Wall Street Bets on Fertility Benefits // CNBC
I’m a Psychiatrist. I’m Hearing Something New From Young Women. // New York Times
Interpol Isn’t Coming for Abortion Pills // The 19th
